1 unchanged sentence
Our common stock is traded on the NASDAQ Global Market, under the symbol KEQU.
−Removed: The following table sets forth the quarterly high and low prices reported on the NASDAQ Global Market for our stock over the last two fiscal years.
−Removed: Quarter Second
−Removed: Quarter Third
−Removed: Quarter Fourth
−Removed: High $11.10 $11.35 $13.45 $13.43
−Removed: Low $8.50 $8.20 $8.08 $11.99
−Removed: Close $9.52 $8.20 $13.20 $12.00
−Removed: High $23.00 $18.20 $19.57 $12.80
−Removed: Low $16.18 $15.06 $12.30 $6.96
−Removed: Close $18.25 $16.09 $12.56 $10.23
−Removed: As of July 6, 2021, we estimate there were approximately 1,092 holders of our common shares, of which 126 were stockholders of record.
−Removed: We paid cash dividends per share of $0.38 for fiscal year 2020.
−Removed: On December 16, 2019, the Company announced that the Board of Directors had elected to suspend the Company's dividend.
−Removed: The declaration and payment of any future dividends will be at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial conditions, the terms of the Company's indebtedness, which currently contains provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant.
+Added: As of June 28, 2022, we estimate there were approximately 964 holders of our common shares, of which 118 were stockholders of record.
+Added: The declaration and payment of any future dividends is at the discretion of the Board of Directors and will depend upon many factors, including the Company's earnings, capital requirements, investment and growth strategies, financial conditions, the terms of the Company's indebtedness, which has contained, and may contain in the future, provisions that could limit the payment of dividends in certain circumstances, and other factors that the Board of Directors may deem to be relevant.
SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS
See Item 12 , Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters , in this Form 10-K for a discussion of securities authorized for issuance under our equity compensation plans.
−Removed: Selected Financial Data
−Removed: The following tables set forth selected historical consolidated financial and other data for the periods indicated.
−Removed: The consolidated financial data should be read in conjunction with Item 8 , Financial Statements and Supplementary Data , and with Item 7 , Management's Discussion and Analysis of Financial Condition and Results of Operations .
−Removed: Twelve Months Ended April 30,
−Removed: $ and shares in thousands, except per share amounts 2021 2020
−Removed: OPERATING STATEMENT DATA:
−Removed: Net sales $ 147,469 $ 147,540
−Removed: Cost of products sold 123,476 124,113
−Removed: Gross profit 23,993 23,427
−Removed: Operating expenses 25,309 25,772
−Removed: Operating loss (1,316) (2,345)
−Removed: Pension expense (1,153) (454)
−Removed: Other income, net 241 426
−Removed: Interest expense (389) (493)
−Removed: Loss before income taxes (2,617) (2,866)
−Removed: Income tax expense 990 1,758
−Removed: Net loss (3,607) (4,624)
−Removed: net earnings attributable to non-controlling interest 65 63
−Removed: Net loss attributable to Kewaunee Scientific Corporation $ (3,672) $ (4,687)
−Removed: Weighted average shares outstanding:
−Removed: Basic 2,760 2,750
−Removed: Diluted 2,760 2,750
−Removed: PER SHARE DATA:
−Removed: Net loss attributable to Kewaunee Scientific Corporation stockholders
−Removed: Basic $ (1.33) $ (1.70)
−Removed: Diluted $ (1.33) $ (1.70)
−Removed: Cash dividends $ — $ 0.38
−Removed: Year-end book value $ 15.05 $ 13.97
−Removed: As of April 30
−Removed: $ in thousands 2021 2020
−Removed: BALANCE SHEET DATA:
−Removed: Current assets $ 60,457 $ 54,231
−Removed: Current liabilities 34,181 27,060
−Removed: Net working capital 26,276 27,171
−Removed: Net property, plant and equipment 15,982 16,272
−Removed: Total assets 89,384 83,929
−Removed: Total borrowings/long-term debt 16,148 13,913
−Removed: Kewaunee Scientific Corporation stockholders' equity 41,241 38,415
−Removed: Capital expenditures $ 2,397 $ 2,465
−Removed: Year-end stockholders of record 125 125
−Removed: Year-end full-time employees (Domestic) 543 623
−Removed: Year-end full-time employees (International) 295 289
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.